Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- FOR-NS-25-004
- Assistance listing (CFDA)
- 93.853
Amount
Amount not published by the funder
Who can apply
About this opportunity
The National Institute of Neurological Disorders and Stroke, on behalf of the NIH Blueprint for Neuroscience Research (NIH Blueprint) and BRAIN Intitiative, intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the ACTION (Academic Career Transition Initiative for Opportunities in Neuroscience) Potential F99/K00 award to support a defined pathway across career stages for skilled neuroscience graduate students performing neuroscience research within the missions of the NIH Blueprint and/or BRAIN Initiative. This two-phase award will facilitate completion of the doctoral dissertation and transition of talented graduate students to strong neuroscience research postdoctoral positions, and will provide career development opportunities relevant to their long-term ...
Related opportunities
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)National Institutes of HealthCloses Oct 2028
- BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)National Institutes of HealthCloses Oct 2027
- BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)National Institutes of HealthCloses in 84 days
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)National Institutes of Health
- NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)National Institutes of HealthCloses in 59 days
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Feb 2027